Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.210
-0.004 (-2.05%)
At close: Dec 20, 2024, 4:00 PM
0.228
+0.018 (8.33%)
After-hours: Dec 20, 2024, 7:49 PM EST
Viracta Therapeutics Market Cap
Viracta Therapeutics has a market cap or net worth of $8.35 million as of December 20, 2024. Its market cap has decreased by -55.81% in one year.
Market Cap
8.35M
Enterprise Value
4.13M
1-Year Change
-55.81%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since February 25, 2021, Viracta Therapeutics's market cap has decreased from $8.68M to $8.35M, a decrease of -3.88%. That is a compound annual growth rate of -1.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 8.35M | -62.09% |
| Dec 29, 2023 | 22.02M | -60.52% |
| Dec 30, 2022 | 55.77M | -59.05% |
| Dec 31, 2021 | 136.19M | 1,468.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 8.78M |
| COSCIENS Biopharma | 8.55M |
| Aytu BioPharma | 8.49M |
| CERo Therapeutics Holdings | 8.43M |
| XWELL | 8.41M |
| RedHill Biopharma | 8.32M |
| Aethlon Medical | 8.10M |
| Meihua International Medical Technologies | 8.08M |